Transplantation of Rat Mesenchymal Stem Cells Overexpressing Hypoxia-Inducible Factor 2α Improves Blood Perfusion and Arteriogenesis in a Rat Hindlimb Ischemia Model
Mesenchymal stem cells (MSCs) have been increasingly tested in cell-based therapy to treat numerous diseases. Genetic modification to improve MSC behavior may enhance posttransplantation outcome. This study aims to test the potential therapeutic benefits of rat bone marrow MSCs overexpressing hypoxi...
Main Authors: | Weifeng Lu, Xiaoli Chen, Yi Si, Shichai Hong, Zhengyu Shi, Weiguo Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2017/3794817 |
Similar Items
-
Notch signaling-modified mesenchymal stem cells improve tissue perfusion by induction of arteriogenesis in a rat hindlimb ischemia model
by: Shusaku Maeda, et al.
Published: (2021-01-01) -
Extracellular Matrix Hydrogel Promotes Tissue Remodeling, Arteriogenesis, and Perfusion in a Rat Hindlimb Ischemia Model
by: Jessica L. Ungerleider, BS, et al.
Published: (2016-01-01) -
New therapeutic approach for impaired arteriogenesis in diabetic mouse hindlimb ischemia
by: Bir, Shyamal Chandra
Published: (2010) -
Anthrax Toxin Receptor 1 Is Essential for Arteriogenesis in a Mouse Model of Hindlimb Ischemia.
by: N J Andersen, et al.
Published: (2016-01-01) -
Therapeutic potential of mesenchymal stem cells for peripheral artery disease in a rat model of hindlimb ischemia
by: Amani Ali, et al.
Published: (2021-06-01)